Citations 2
Tocilizumab and Satralizumab in MOGAD: Real-world Outcomes for Relapse Prevention (P3-1.002)
Vilaseca-Jolonch, Andreu, Syc-Mazurek, Stephanie, Guo, Kai, Niederschweiberer, Moritz, Sagen, Jessica, Lopez-Chiriboga, Sebastian, Wingerchuk, Dean, Tillema, Jan-Mendelt, Pittock, Sean, Chen, John, Flanagan, Eoin , Thakolwiboon, Smathorn , Syc‐Mazurek, Stephanie B. , Cacciaguerra, Laura , Niederschweiberer, Moritz , López‐Chiriboga, A. Sebastian , Tillema, Jan‐Mendelt , Pittock, Sean J. , Flanagan, Eoin P.
Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available
Myelin Alterations Within and Beyond Lesions in MOG Antibody-associated Disease: Insights from Ultra-high field (7T) MRI (S6.002)
Fagan, Andrew, Port, John, Morris, Pearse, Chen, John, Tobin, W., Pittock, Sean, Tillema, Jan-Mendelt, Flanagan, Eoin , Cacciaguerra, Laura , Fagan, Andrew, Port, John D. , Pittock, Sean J. , Tillema, Jan‐Mendelt , Flanagan, Eoin P.
Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available